Study record managers: refer to the Data Element Definitions if submitting registration or results information.
|1||NCT03257761||Recruiting||Guadecitabine and Durvalumab in Treating Patients With Advanced Liver, Pancreatic, Bile Duct, or Gallbladder Cancer||
||Other / NIH||
||90||All||18 Years and older (Adult, Older Adult)||NCT03257761||0S-16-18
|February 7, 2018||February 7, 2021||February 20, 2022||August 22, 2017||May 3, 2019||